AU2001240561A1 - Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments - Google Patents

Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments

Info

Publication number
AU2001240561A1
AU2001240561A1 AU2001240561A AU4056101A AU2001240561A1 AU 2001240561 A1 AU2001240561 A1 AU 2001240561A1 AU 2001240561 A AU2001240561 A AU 2001240561A AU 4056101 A AU4056101 A AU 4056101A AU 2001240561 A1 AU2001240561 A1 AU 2001240561A1
Authority
AU
Australia
Prior art keywords
paarm
medicaments
production
receptor modulators
positive allosteric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240561A
Other languages
English (en)
Inventor
Stefen Matthias Blech
Angelo Ceci
Thomas Weiser
Karin Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of AU2001240561A1 publication Critical patent/AU2001240561A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001240561A 2000-02-02 2001-01-30 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments Abandoned AU2001240561A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10004572 2000-02-02
DE10004572A DE10004572A1 (de) 2000-02-02 2000-02-02 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2001/000960 WO2001057045A1 (fr) 2000-02-02 2001-01-30 Nouveaux modulateurs (paarm) allosteriques positifs de recepteurs ampa, leur methode de production et leur utilisation comme medicaments

Publications (1)

Publication Number Publication Date
AU2001240561A1 true AU2001240561A1 (en) 2001-08-14

Family

ID=7629599

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240561A Abandoned AU2001240561A1 (en) 2000-02-02 2001-01-30 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments

Country Status (16)

Country Link
US (3) US6525045B2 (fr)
EP (1) EP1265904B1 (fr)
JP (1) JP4891510B2 (fr)
AR (1) AR027352A1 (fr)
AT (1) ATE277054T1 (fr)
AU (1) AU2001240561A1 (fr)
CA (1) CA2399377C (fr)
CO (1) CO5261505A1 (fr)
DE (2) DE10004572A1 (fr)
DK (1) DK1265904T3 (fr)
ES (1) ES2228817T3 (fr)
MX (1) MXPA02007460A (fr)
PT (1) PT1265904E (fr)
TR (1) TR200402650T4 (fr)
UY (1) UY26566A1 (fr)
WO (1) WO2001057045A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CN1416346A (zh) * 2000-03-21 2003-05-07 史密丝克莱恩比彻姆公司 蛋白酶抑制剂
KR100982753B1 (ko) * 2001-04-05 2010-09-16 콜라제넥스 파마슈티칼스, 인크 테트라사이클린 화합물 및 테트라사이클린 유도체의 전달조절
DE10123952A1 (de) * 2001-05-17 2002-11-21 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20030100552A1 (en) 2001-05-17 2003-05-29 Boehringer Ingelheim Pharma Kg Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions
CN1275951C (zh) * 2001-10-10 2006-09-20 神经研究公司 新的苯并噻嗪衍生物、其制备和应用
US7815391B2 (en) * 2004-07-23 2010-10-19 Kauppila Richard W Structural member joints
WO2006034196A1 (fr) * 2004-09-17 2006-03-30 Lifelike Biomatic Inc. Compositions pour renforcer la mémoire et procédés idoines
CA2721644C (fr) * 2008-05-05 2013-10-15 Matthieu Giraud Groupes protecteurs a base d'indole sulfonyle pour la protection de groupes guanidine et amino
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
CN105579575A (zh) 2013-06-13 2016-05-11 维罗技术有限责任公司 用于治疗代谢失调的组合物和方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
US4994452A (en) * 1989-11-28 1991-02-19 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
HUT70955A (en) * 1992-04-15 1995-11-28 Rhone Poulenc Rorer Sa 3,4-dihydro-1,1-dioxo-2h-1,2,4-benzothiadiazine-3-carboxylic acid derivatives, preparation thereof and drugs containing same
RU2145606C1 (ru) * 1994-05-24 2000-02-20 Ф.Хоффманн-Ля Рош Аг Трициклические дикарбонильные производные и лекарственный препарат на их основе
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
US5968928A (en) * 1996-09-19 1999-10-19 Warner-Lambert Company Excitatory amino acid antagonists: fused-azacyclic quinoxalinediones and immunoassays thereof
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response
EE200000468A (et) * 1998-02-18 2002-04-15 Neurosearch A/S Ühendid, nende kasutamine ja farmatseutiline kompositsioon
US6096744A (en) * 1998-05-04 2000-08-01 Warner-Lambert Company Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
WO2001057045A1 (fr) 2001-08-09
ATE277054T1 (de) 2004-10-15
MXPA02007460A (es) 2003-01-28
CA2399377C (fr) 2008-12-16
PT1265904E (pt) 2004-11-30
AR027352A1 (es) 2003-03-26
JP4891510B2 (ja) 2012-03-07
US6800623B2 (en) 2004-10-05
DK1265904T3 (da) 2004-10-25
CO5261505A1 (es) 2003-03-31
EP1265904A1 (fr) 2002-12-18
EP1265904B1 (fr) 2004-09-22
JP2003522180A (ja) 2003-07-22
US6525045B2 (en) 2003-02-25
CA2399377A1 (fr) 2001-08-09
DE10004572A1 (de) 2001-08-09
DE50103760D1 (de) 2004-10-28
UY26566A1 (es) 2001-08-27
US20020013313A1 (en) 2002-01-31
TR200402650T4 (tr) 2004-11-22
US20030158181A1 (en) 2003-08-21
US20030158183A1 (en) 2003-08-21
ES2228817T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2002219174A1 (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
AU2002219173A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2002231688A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2001295481A1 (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
AU6383101A (en) Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
AU763094C (en) Benzimidazoles, production thereof and use thereof as medicaments
AU2003265589A1 (en) Process for the preparation of 1,1,1,2,2-pentafluoroethane
WO2001010816A3 (fr) Derives de 2-dialkylaminoalkylbiphenyle
AU2001241056A1 (en) Spiro compounds, process for preparing the same and use thereof as drugs
AU2001289814A1 (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
AU2002214006A1 (en) Drugs for diabetes
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
AU2001240561A1 (en) Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments
WO2002060906A3 (fr) Modification de cristaux
AU2001291865A1 (en) Silicon-boron-carbon-nitrogen ceramics and precursor compounds, methods for the production and use thereof
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU2001260110A1 (en) Novel LHRH-antagonists, Production and Use Thereof as Medicament
AU2001262229A1 (en) Cyclipostins, a method for their production and the use of the same
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU1021001A (en) Cyclic biphenyls, method for the production thereof, and their use as medicaments
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient